Find, compare & contact
Insulin Degludec
API Manufacturers & Suppliers
Malaysia
India
Contact suppliers
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Insulin Degludec is listed?
Join our notification list by following this page.
Join our notification list by following this page.
List your company
Are you a supplier of Insulin Degludec or other APIs and are you looking to list your company on Pharmaoffer?
Click the button below to find out more
Click the button below to find out more
Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?
Click the button below to switch over to the contract services area of Pharmaoffer.
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Insulin Degludec API 844439-96-9?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Insulin Degludec. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Insulin Degludec
- Cas Number:
- 844439-96-9
- DrugBank number:
- DB09564
- Unique Ingredient Identifier:
- NN-1250;NN1250
About Insulin Degludec
Insulin Degludec, marketed under brand names like Tresiba, is an ultra-long-acting form of insulin, used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes. Unlike conventional insulin, it has an added hexadecanedioic acid on lysine at the B29 position, facilitating the formation of multi-hexamers upon subcutaneous injection. This unique structure allows for a protracted action profile, providing a consistent level of basal insulin over 42 hours with a low peak: trough ratio. Insulin Degludec's effectiveness in glycemic control makes it a vital component in diabetes management, particularly benefiting patients requiring stable and prolonged insulin action.
